AAIC 2026 | Improving racial and ethnic representation in Alzheimer’s disease clinical trials

Omonigho Michael Bubu, MD, MPH, PhD, NYU Grossman School of Medicine, New York City, NY, comments on the underrepresentation of certain populations in Alzheimer’s disease clinical trials. Dr Bubu emphasizes the need to include and report on all racial and ethnic groups to better understand the disease and inform treatment decisions. This interview took place at the 2026 Alzheimer’s Association International Conference (AAIC) in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.